BMJ  2006;332:1419 (17 June), doi:10.1136/bmj.38849.487546.DE (published 31 May 2006)

Research

Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study

¹ Institute for Clinical Evaluative Sciences G106-2075 Bayview Avenue, Toronto, Ontario M4N 3M5 (Note to Author: We give only one address per author), ² Institute for Work and Health, Toronto, ³ Department of Health Policy, Management and Evaluation, University of Toronto, ⁴ Central East Health Information Partnership, Toronto

Abstract

Objective To examine the potential effectiveness and efficiency of different guidelines for statin treatment to reduce deaths from coronary heart disease in the Canadian population.

Design Modelled outcomes of screening and treatment recommendations of six national or international guidelines—from Canada, Australia, New Zealand, the United States, joint British societies, and European societies.

Setting Canada.

Data sources Details for 6760 men and women aged 20-74 years from the Canadian Heart Health Survey (weighted sample of 12 300 000 people) that included physical measurements including a lipid profile.

Main outcome measures The number of people recommended for treatment with statins, the potential number of deaths from coronary heart disease avoided, and the number needed to treat to avoid one coronary heart disease death with five years of statin treatment if the recommendations from each guideline were fully implemented.

Results When applied to the Canadian population, the Australian and British guidelines were the most effective, potentially avoiding the most deaths over five years (> 15 000 deaths). The New Zealand guideline was the most efficient, potentially avoiding almost as many deaths (14 700) while recommending treatment to the fewest number of people (12.9% of people v 17.3% with the Australian and British guidelines). If their "optional" recommendations are included, the US guidelines recommended treating about twice as many people as the New Zealand guidelines (24.5% of the population, an additional 1.4 million people) with almost no increase in the number of deaths avoided.

Conclusions By focusing recommendations on people with the highest risk of coronary heart disease, the Canadian, US, and European societies guidelines could improve either their effectiveness (in terms of hundreds of avoided deaths) or efficiency (in terms of thousands of fewer people recommended treatment) in the Canadian population.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Statin guidelines should give best statin

Hisashi Moriguchi, Takamoto Uemura, and Chifumi Sato
BMJ 2006 333: 46. [Extract] [Full Text]

Guidelines on statin treatment should focus on high risk patients
BMJ 2006 332: 0. [Full Text]

Kidney function tests plus data on proteinuria give better estimate of mortality risk
BMJ 2006 332: 0. [Full Text]

Disease impact number and population impact number: population perspectives to measures of risk and benefit • Commentary: DINS, PINS, and thingsclinical and population perspectives on treatment effects

Richard F Heller, Annette J Dobson, Liam Smeeth, and Shah Ebrahim
BMJ 2000 321: 950-953. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Vickers, A. J., Basch, E., Kattan, M. W. (2008). Against Diagnosis. ANN INTERN MED 149: 200-203 [Abstract] [Full text]  
• Krumholz, H. M., Masoudi, F. A. (2007). The Year in Epidemiology, Health Services Research, and Outcomes Research. J Am Coll Cardiol 50: 2254-2262 [Full text]  
• Fidan, D., Unal, B., Critchley, J., Capewell, S. (2007). Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010. QJM 100: 277-289 [Abstract] [Full text]  
• Singh, S. M., Austin, P. C., Chong, A., Alter, D. A. (2007). Coronary Angiography Following Acute Myocardial Infarction in Ontario, Canada. Arch Intern Med 167: 808-813 [Abstract] [Full text]  
• (2006). Comparison of International Statin Guidelines. JWatch General 2006: 6-6 [Full text]  
• Moriguchi, H., Uemura, T., Sato, C. (2006). Statin guidelines should give best statin.. BMJ 333: 46-46 [Full text]  
• Madhok, V., Fahey, T. (2006). Cardiovascular risk estimation: important but may be inaccurate. BMJ 332: 1422-1422 [Full text]  

Rapid Responses:

Read all Rapid Responses

How do the JBS 2 Guidelines perform?

H Michael Power
bmj.com, 1 Jun 2006 [Full text]

Guidelines on statin treatment should focus on high risk patients and show the optimal choice of statins.

Hisashi Moriguchi, et al.
bmj.com, 16 Jun 2006 [Full text]

Wanted: More Subgroup Analyses and NNH

Maryann Napoli
bmj.com, 19 Jun 2006 [Full text]

New Zealand Guidelines are Unworkable in Real Life

Paul A Corwin
bmj.com, 20 Jul 2006 [Full text]